Skip to content

Randomized Arthrex Nano Arthroscopy in Arthroscopic ACL vs Conventional Arthroscopy

Randomized Study Evaluating Cost of Arthrex Nano Arthroscopy Products in Arthroscopic Knee ACL Surgery Versus Conventional Arthroscopy

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07553975
Enrollment
42
Registered
2026-04-28
Start date
2026-05-01
Completion date
2029-05-01
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament

Brief summary

The study is a pilot study designed to generate preliminary data regarding the cost of ACL surgery using NanoScope versus conventional arthroscopy in a traditional operating room (OR) setting.

Interventions

DEVICEACL surgery using Arthrex NanoScope

The rod-lens arthroscope has been the standard of care in the operating room for more than 40 years. Arthrex's all-in-one disposable, 2 mm, chip-on-tip camera system now allows surgeons to miniaturize their treatment solutions.

PROCEDUREACL surgery using conventional arthroscopy

Conventional arthroscopy using standard of care equipment

Sponsors

University of Colorado, Denver
Lead SponsorOTHER
Arthrex, Inc.
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject is 18 - 60 years of age. * Subject body mass index (BMI) is 40 or lower (BMI ≤ 40). * Subject signed informed consent and is willing and able to comply with all study requirements and follow-up visits. * Confirmed ACL injury by MRI and physical exam as per standard of care. * Subjects not excluded for having meniscal pathology that requires resection or repair. * Subjects not excluded for having lateral-extra-articular tenodesis

Exclusion criteria

* Revision ACL case. * Current bilateral knee injury. * Insufficient quantity or quality of bone. * Blood supply limitations and previous infections which may retard healing. * Subjects that are skeletally immature. * Advanced Osteoarthritis; Kellgren Lawrence ≥ 2 * Fracture of the lower extremities within 6 months prior to screening. * Previous surgery on the affected knee within 12 months related to the ACL reconstruction, prior to screening. * Sensitivity to silicone, polyester, nylon, FD\&C Blue No. 2 dye and beeswax. * Other concomitant disease that would interfere with study outcomes. * Subject is included in a vulnerable population (child, prisoner, etc.). * Conditions that tend to limit the patient's ability or willingness to restrict activities, follow directions, or perform online subject assessments during the healing period. * Subject is requesting or receiving Worker's compensation related to the knee injury.

Design outcomes

Primary

MeasureTime frameDescription
Compare patient satisfaction for Anterior Cruciate Ligament (ACL) surgery when using either Arthrex Nanoscope 2.0 or conventional arthroscopy.From enrollment to 2 years1\. Patient Reported Outcomes Knee Injury and Osteoarthritis Outcome Score (KOOS)

Secondary

MeasureTime frameDescription
Operating Room (OR) metrics that may be correlated with staff satisfaction and operating team satisfaction.immediately postoperatively7\. OR Metrics Surgical Time, Units: Minutes

Contacts

CONTACTGregory Ottenberg
GREGORY.OTTENBERG@CUANSCHUTZ.EDU303-724-6538
CONTACTHana Durkee
hana.durkee@cuanschutz.edu
PRINCIPAL_INVESTIGATORRachel M Frank, MD

University of Colorado, Denver

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026